GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) — Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the pricing of an underwritten public offering of 8,000,000 shares of common stock at a price to the public of $5.00 per share, and in lieu of common stock, to certain investors, pre-funded warrants to purchase 8,000,000 shares of common stock at a purchase price of $4.999 per pre-funded warrant share, which equals the public offering price per share of the common stock less the $0.001 exercise price per share of each pre-funded warrant. The gross proceeds to Senseonics from the offering, before deducting underwriting discounts and commissions...

AUSTIN, Texas, April 30, 2026 (GLOBE NEWSWIRE) — Rein Therapeutics, Inc. (“Rein” or the “Company”) (NASDAQ: RNTX), a clinical-stage biopharmaceutical company advancing a novel pipeline of first-in-class medicines for orphan pulmonary and fibrosis indications, today announced the pricing of its underwritten public offering of fifty million shares of its common stock at a public offering price of $1.00 per share for aggregate gross proceeds of $50 million, prior to deducting underwriting discounts and commissions and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 7.5M shares of common stock at the public offering price per share, less the underwriting discounts and commissions, to cover over-allotments, if any. The offering is expected...

VANCOUVER, British Columbia, April 30, 2026 (GLOBE NEWSWIRE) — Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) (the “Company”) will release its first quarter 2026 financial results after market close on Wednesday, May 6, 2026. The Company will host a telephone conference call and live webcast on Thursday, May 7, 2026, at 11:00 a.m. Eastern Time (8:00 a.m. Pacific) to discuss these results. After opening remarks by management, there will be a question and answer session open to analysts and investors. The conference call may be accessed by dialing 800-715-9871 toll free or 646-307-1963, using the access code 3266924. The webcast may be accessed at tasekomines.com/investors/events and will be archived until May 7, 2027 for later playback. For further information on Taseko, see the Company’s website at tasekomines.com...

NEW YORK & TORONTO, April 30, 2026 (GLOBE NEWSWIRE) — In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring Treatment Solutions (“VETS”) have been removed from the first, third and fourth paragraphs.  The corrected release follows:  Helus Pharma Partners with TARA Mind to Advance Veteran Mental HealthCollaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark Executive Order on breakthrough mental health treatmentsHelus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced a collaboration with TARA...

SAN JOSE, Calif., April 30, 2026 (GLOBE NEWSWIRE) — California Water Service (Cal Water), the largest subsidiary of California Water Service Group (Group) (NYSE: CWT), received a final decision on its 2024 General Rate Case and Infrastructure Improvement Plan from the California Public Utilities Commission (CPUC) on April 30, 2026. The Company believes the decision enables Cal Water to invest responsibly in water system infrastructure through 2027 to support its communities and sets Cal Water’s revenue and rates to help sustain safe, clean, reliable water service through 2028. The CPUC adopted the proposed decision (PD) issued March 13, 2026 with revisions issued on April 29, 2026 (revised PD). The final decision increases Cal Water’s company-wide revenues by $90.5 million in 2026 (a rate increase of 10.9%), $43.2 million in 2027...

CALGARY, Alberta, April 30, 2026 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE) (TSX:GTE) (LSE: GTE) announces that the Company will release its 2026 first-quarter financial and operating results on Thursday, May 7, 2026, post-market. Gran Tierra will host its first quarter 2026 results conference call on Friday, May 8, 2026, at 9:00 a.m. Mountain Time, 11:00 a.m. Eastern Time. Gran Tierra’s 2026 Annual Meeting of Stockholders will be held on Friday, May 8, 2026, at 10:00 a.m. Mountain Time, 12:00 p.m. Eastern Time. Our Annual Meeting will be held as a virtual-only stockholder meeting with participation occurring electronically as explained further in the Proxy Statement dated March 17, 2026. How to Participate in the Virtual Annual Meeting Shareholders can participate electronically...

CAMBRIDGE, Mass. and COPENHAGEN, Denmark, April 30, 2026 (GLOBE NEWSWIRE) — Hemab Therapeutics Holdings, Inc. (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience, today announced the pricing of its initial public offering of 16,750,000 shares of its common stock at a public offering price of $18.00 per share. In addition, Hemab has granted the underwriters a 30-day option to purchase up to an additional 2,512,500 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock are being offered by Hemab. Hemab’s common stock is expected to begin trading on the Nasdaq Global Select Market on Friday, May 1, 2026 under the ticker symbol “COAG.” The...

CHATTANOOGA, Tenn., April 30, 2026 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), a leading battery materials company, today announced that it has finalized and closed the previously announced sale of its NOVONIX Battery Technology Solutions Inc. (“BTS”) business in Nova Scotia, Canada, to its former Chief Executive Officer, Dr. Chris Burns (“Buyer”). “The divestiture of the BTS division reflects our disciplined strategy of building a vertically integrated synthetic graphite supply chain in North America,” said Mike O’Kronley, CEO of NOVONIX. “By divesting non-core business segments, we are directing our management attention and capital toward advancing domestic supply of this critical mineral and supporting the growth of the North American battery industry.” Founded in 2013 by Dr. Chris...

CALGARY, Alberta, April 30, 2026 (GLOBE NEWSWIRE) — TransAlta Corporation (TSX: TA) (NYSE: TAC) (“TransAlta” or the “Company”) held its Annual and Special Meeting of Shareholders (“the Meeting”) on April 30, 2026. The total number of common shares represented by shareholders at the Meeting and by proxy was 188,939,751, representing 63.55 per cent of the Company’s outstanding common shares. The following resolutions were considered by shareholders: Election of Directors The nine director nominees proposed by management were elected. The votes by ballot were received as follows:Nominee Votes For Per cent Against Per centBrian Baker 169,367,796 92.54 13,662,120 7.46John P. Dielwart 181,971,364 99.42 1,058,552 0.58Laura W. Folse 182,079,603 99.48 950,310 0.52Joel E. Hunter 182,377,197 99.64 652,249 0.36Thomas...